Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 21, 2016
[ Thu, Jan 21st 2016
] - WOPRAI
[ Thu, Jan 21st 2016
] - WOPRAI
[ Thu, Jan 21st 2016
] - WOPRAI
[ Thu, Jan 21st 2016
] - WOPRAI
[ Thu, Jan 21st 2016
] - WOPRAI
[ Thu, Jan 21st 2016
] - WOPRAI
[ Thu, Jan 21st 2016
] - WOPRAI
Wed, January 20, 2016
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
Alethia Young Initiated (ALNY) at Buy and Held Target at $154 on, Jan 20th, 2016
Alethia Young of Credit Suisse, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $154 on, Jan 20th, 2016.
Alethia has made no other calls on ALNY in the last 4 months.
There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Alethia's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alethia
- Paul Matteis of "Leerink Swann" Maintained at Buy with Increased Target to $152 on, Tuesday, November 10th, 2015
Similar Stocks and Investing Articles
[ Wed, Dec 23rd 2015
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
[ Thu, Sep 17th 2015
] - WOPRAI
[ Mon, Aug 31st 2015
] - WOPRAI
[ Mon, Jun 15th 2015
] - WOPRAI
[ Fri, Feb 27th 2015
] - WOPRAI
[ Fri, Feb 20th 2015
] - WOPRAI
[ Tue, Feb 25th 2014
] - WOPRAI
[ Tue, Dec 31st 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI